Evidence map›Paper›PMID 40600591›Full record

ArticleAnalytical chemistry2025

Single Molecule Kinetic Fingerprinting of Glycans on IgA1 Antibodies.

Joseph R Rubin, Steven K Taylor, Sergei Rudchenko, Milan N Stojanovic, Henry Hess

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joseph R RubinDepartment of Biomedical Engineering, Columbia University, 1210 Amsterdam Ave., New York, New York 10027, United States.
Steven K TaylorDivision of Experimental Therapeutics, Department of Medicine, Columbia University, 630 W. 168th St., New York, New York 10032, United States.ORCID 0000-0002-9810-4531
Sergei RudchenkoDivision of Experimental Therapeutics, Department of Medicine, Columbia University, 630 W. 168th St., New York, New York 10032, United States.
Milan N StojanovicDepartment of Biomedical Engineering, Columbia University, 1210 Amsterdam Ave., New York, New York 10027, United States.
Henry HessDepartment of Biomedical Engineering, Columbia University, 1210 Amsterdam Ave., New York, New York 10027, United States.ORCID 0000-0002-5617-606X

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
NRSA Training CoreTL1TR001875 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPANN, MARISA N, TAYLOR, JACQUELYN Y · 2016 to 2025
$8.9M
Single molecule oligopeptide fingerprinting based on templated self-assembly of oligonucleotide structuresR21HG012543 · NHGRI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HESS, HENRY · 2022 to 2023
$534k
NCATS NIH HHS TL1 TR001875NCATS NIH HHS UL1 TR001873NHGRI NIH HHS R21 HG012543
6 · The paper itself

Abstract

Immunoglobulin A (IgA) nephropathy is the most common form of primary glomerulonephritis and is triggered by damage to glomeruli from deposition of complexes formed between glycosylated IgA1 antibodies that are "galactose-deficient" and antibodies directed to these aberrant proteins. Currently, galactose deficiencies are detected with ensemble measurements, e.g., via mass spectrometry or liquid chromatography, which only measure average glycan-IgA1 ratios, but cannot resolve heterogeneity of O-glycosylation between different IgA1 populations. To resolve these differences at the single molecule level, we developed an assay to detect the glycosylation state of individual IgA1 using single molecule fluorescence microscopy. By using fluorescence resonance energy transfer (FRET), high concentrations of fluorescently labeled probes with low binding rates can be employed to observe the binding of protein probes to surface adhered target molecules and obtain their kinetic fingerprints. We measured the binding and unbinding rates of jacalin (a lectin binding to O-linked glycans) to individual IgA1 molecules on a glass surface. Adding galactose decreased binding, which demonstrated that the jacalin probe binds specifically to O-linked glycans on the hinge region of IgA1. This result is a first step toward using kinetic fingerprinting to sequence glycans on IgA1.

Indexed as

Immunoglobulin APolysaccharidesFluorescence Resonance Energy TransferGalactoseGlycosylationHumansKineticsMicroscopy, FluorescencePlant LectinsGalactoseImmunoglobulin AjacalinPlant LectinsPolysaccharides

Identifiers

PMID40600591
PMCPMC12282526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.